The Quiet Exit From Commercial Contracts
Psychiatric billing groups that built their practices around commercial insurance contracts are stepping back from those agreements at a rate that would have seemed unlikely five years ago. The exits are not dramatic – no press releases, no public announcements – but the pattern is consistent enough across regional markets that it signals something structural rather than situational. Groups are deciding, one contract cycle at a time, that the math no longer works.
The decision to drop commercial insurance is not new in mental health care, but it has historically been the move of solo practitioners and small therapy practices. What is different now is the scale of the groups making that call. Multi-provider psychiatric billing organizations – the kind that handle medication management, intake, and outpatient psychiatric care across multiple counties – are the ones quietly restructuring their payer mix. That shift carries consequences far beyond the groups themselves.
Why the Numbers Stopped Working
Commercial insurers reimburse psychiatric services at rates that have not kept pace with the actual cost of delivering that care. A psychiatric evaluation that takes 60 to 90 minutes, requires a licensed prescriber, and involves significant administrative follow-up gets reimbursed at rates that insurers set largely based on historical benchmarks, not current operational costs. When those benchmarks were established, staff salaries were lower, credentialing requirements were less intensive, and the volume of documentation that payers demand was a fraction of what it is today.
The billing side of psychiatry has become its own burden. Commercial payers require prior authorizations for medication management visits at a far higher rate than other specialties. A group billing for 200 psychiatric appointments a week may spend the equivalent of one full-time staff position just managing authorization requests, appeals, and denials. That cost does not show up in any reimbursement rate negotiation. It simply gets absorbed by the practice until the practice can no longer absorb it.
Groups that have already exited commercial networks describe the relief as immediate. The administrative overhead drops sharply. Providers spend more time in clinical contact and less time managing payer disputes. The irony is that the same insurers whose rate structures drove these groups out are now facing network adequacy complaints from their own members – patients who enrolled in a plan expecting psychiatric coverage and are finding no in-network providers within a reasonable distance.
Where Patients End Up
When a regional psychiatric billing group exits a commercial network, the patients don’t disappear. They redistribute – some to remaining in-network providers who are often already at capacity, some to federally qualified health centers that operate outside the commercial insurance framework, and some to no care at all. The gap between psychiatric need and accessible psychiatric care was already wide. Each group exit makes it wider.
A growing number of these groups are moving toward a hybrid model: they retain Medicare and Medicaid contracts, which carry their own rate problems but come with different administrative structures, while shifting their commercial patient base to self-pay or sliding-scale arrangements. That model works in markets where patients have the financial flexibility to pay out of pocket – which is not most markets. This pattern is not unlike what has been documented in other specialty billing sectors; regional ambulance billing groups exiting Medicare contracts have followed a similar logic of calculating which payer relationships cost more to maintain than they return.
The Structural Pressure Behind the Exits
Commercial insurers have long used narrow reimbursement rates as an implicit supply control mechanism – keeping psychiatric providers in network by offering patient volume in exchange for discounted fees. That leverage only works if providers believe the volume justifies the discount. When the cost of serving each patient climbs because of regulatory requirements, staffing scarcity, and documentation burdens, the volume argument becomes less persuasive. At a certain threshold, more patients at a bad rate is simply more loss.
Credentialing is its own constraint. Getting a psychiatric provider credentialed with a commercial insurer takes months. During that window, the provider generates no insurance revenue. Groups with high provider turnover – and psychiatry has high turnover – are constantly cycling through that credentialing lag, subsidizing the onboarding cost with cash reserves that smaller regional groups may not have. Some groups have reported spending more on credentialing administration than on clinical training in a given year.
There is also the question of what commercial insurers actually cover. Psychiatric care often involves services that payers classify as not medically necessary or not separately billable – psychoeducation components of a visit, care coordination calls, collaborative treatment planning with a patient’s other providers. Groups that bill comprehensively for the work they actually do face systematic downcoding and denial. Groups that bill conservatively to avoid denial leave revenue on the table they cannot afford to lose. Neither path is sustainable.
The groups exiting commercial insurance are not necessarily thriving after they leave. Some are converting to direct-pay concierge models that serve a narrow, wealthier patient population. Others are consolidating with larger health systems that absorb the commercial billing burden at a scale that makes it manageable. A few are simply closing. What they share is the conclusion that continuing to operate as independent commercial billing groups in psychiatry requires accepting losses the market will not compensate – and that the commercial payers who depend on their participation have shown little urgency to change the terms that are driving them out.
